Exploration of Drug Science

Open Exploration

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Exploration of Drug Science is an open-access journal published by Open Exploration in China, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,000 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Open Exploration
ISSN
2836-7677
Country
China
Languages
english
Access
Open access
Declared publication charge
2,000 USD
Articles in DOAJ
179
Declared review time
12 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2025-02-05
Indexing
DOAJ
APC
2,000 USD
Declared review time (DOAJ)
12 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

179

Most recent article

last month

Average review time (journal-declared via DOAJ)

12weeks

Works in OpenAlex

167

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

12

i10-index

18

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2025-02-05
Added to DOAJ
2025-02-05
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
Portico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Editorial board
Official page ↗
Open references deposited at Crossref
96%
ORCID iDs in current deposits
96%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918573686806676
Classification2

Subjects (DOAJ)

Medicine: Pharmacy and materia medica

LCC codes

RS1-441

Subject areas

  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Medicinal Plant Research
  • Antimicrobial Peptides and Activities
  • Chemical Synthesis and Analysis
  • Antimicrobial Peptides and Activities
  • Antimicrobial Peptides and Activities
Show all subjects (75)
  • Nanoparticle-Based Drug Delivery
  • Antimicrobial agents and applications
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Synthesis and Characterization of Heterocyclic Compounds
  • Diabetes Treatment and Management
  • Liver Disease Diagnosis and Treatment
  • Bioactive natural compounds
  • Liver Disease Diagnosis and Treatment
  • Chemical Synthesis and Analysis
  • Chemical Synthesis and Analysis
  • Natural Antidiabetic Agents Studies
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Natural Antidiabetic Agents Studies
  • Protein Hydrolysis and Bioactive Peptides
  • Protein Hydrolysis and Bioactive Peptides
  • Synthesis and biological activity
  • Diabetes Treatment and Management
  • Essential Oils and Antimicrobial Activity
  • Synthesis and biological activity
  • Bioactive Compounds and Antitumor Agents
  • Antibiotic Resistance in Bacteria
  • Click Chemistry and Applications
  • Synthesis and biological activity
  • Diet and metabolism studies
  • Diabetes Treatment and Management
  • RNA Interference and Gene Delivery
  • Liver Disease Diagnosis and Treatment
  • Pharmacological Effects of Natural Compounds
  • Diet and metabolism studies
  • Pharmacological Effects of Natural Compounds
  • Bioactive Compounds and Antitumor Agents
  • Pharmaceutical Economics and Policy
  • Antibiotic Resistance in Bacteria
  • Graphene and Nanomaterials Applications
  • Nanoplatforms for cancer theranostics
  • Phytochemicals and Antioxidant Activities
  • Monoclonal and Polyclonal Antibodies Research
  • Seaweed-derived Bioactive Compounds
  • Essential Oils and Antimicrobial Activity
  • Antibiotic Resistance in Bacteria
  • vaccines and immunoinformatics approaches
  • Essential Oils and Antimicrobial Activity
  • Nanoplatforms for cancer theranostics
  • Graphene and Nanomaterials Applications
  • Pharmaceutical studies and practices
  • Phytochemicals and Antioxidant Activities
  • Flavonoids in Medical Research
  • Microbial Natural Products and Biosynthesis
  • Natural Antidiabetic Agents Studies
  • Phytochemicals and Antioxidant Activities
  • Monoclonal and Polyclonal Antibodies Research
  • Advanced Drug Delivery Systems
  • Bacteriophages and microbial interactions
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Microbial Natural Products and Biosynthesis
  • Probiotics and Fermented Foods
  • Nanoparticles: synthesis and applications
  • Herbal Medicine Research Studies
  • Bacteriophages and microbial interactions
  • Herbal Medicine Research Studies
  • Probiotics and Fermented Foods
  • Advanced Drug Delivery Systems
  • Alzheimer's disease research and treatments
  • Advanced Drug Delivery Systems

Keywords (DOAJ)

  • drug science
  • pharmacology
  • vaccines
  • drug resistance
  • medicinal chemistry
  • drug repurposing

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: